https://www.selleckchem.com/products/tas-120.html
Mean follow-up was 19.4months (range 12-49). Mean postoperative ENS6Q score was 2.1. Only 2.1% had ENS6Q scores ≥ 11, and 6.3% had nasal crusting at last follow-up. None of the patients with ENS6Q scores ≥ 11 had nasal crusting at last follow-up. There were no significant differences in outcomes between ages, genders, surgery types, or pathologies. Patients who underwent bilateral subtotal MTR during ESS were unlikely to develop ENS by at least 1year postoperatively, based on patients rarely experiencing ENS6Q scores ≥ 11 or persistent
إعجاب
علق
شارك
